MiMedx Group Inc (MDXG):企業の製品パイプライン分析

◆英語タイトル:MiMedx Group Inc (MDXG) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME83319PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental tissues, cleans and reassembles layers, and dehydrates the tissue to preserve the key elements associated with healing. MiMedx’s product delivers human extracellular matrix components for regeneration of damaged or diseased tissues. Its products modulate inflammation, reduce scar tissue formation, and enhance healing. The company offers services in the areas of wound care, burn, surgical, orthopaedic, spine, sports medicine, ophthalmic and dental sectors of healthcare. MiMedx is headquartered in Marietta, Georgia, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MiMedx Group Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
MiMedx Group Inc Company Overview
MiMedx Group Inc Company Snapshot
MiMedx Group Inc Pipeline Products and Ongoing Clinical Trials Overview
MiMedx Group Inc – Pipeline Analysis Overview
MiMedx Group Inc – Key Facts
MiMedx Group Inc – Major Products and Services
MiMedx Group Inc Pipeline Products by Development Stage
MiMedx Group Inc Ongoing Clinical Trials by Trial Status
MiMedx Group Inc Pipeline Products Overview
AmnioFix Injectable – Achilles Tendonitis
AmnioFix Injectable – Achilles Tendonitis Product Overview
AmnioFix Injectable – Achilles Tendonitis Clinical Trial
AmnioFix Injectable – Knee OA Pain
AmnioFix Injectable – Knee OA Pain Product Overview
AmnioFix Injectable – Knee OA Pain Clinical Trial
AmnioFix Injectable – Plantar Fasciitis
AmnioFix Injectable – Plantar Fasciitis Product Overview
AmnioFix Injectable – Plantar Fasciitis Clinical Trial
AmnioFix Injectable – Pressure Ulcer
AmnioFix Injectable – Pressure Ulcer Product Overview
CollaFix – Foot & Ankle
CollaFix – Foot & Ankle Product Overview
CollaFix – Rotator Cuff Repair
CollaFix – Rotator Cuff Repair Product Overview
CollaFix BioBraid
CollaFix BioBraid Product Overview
CollaFix Collagen Fiber Suture
CollaFix Collagen Fiber Suture Product Overview
CollaFix Tendon Protector
CollaFix Tendon Protector Product Overview
EpiFix Amniotic Membrane Allograft
EpiFix Amniotic Membrane Allograft Product Overview
EpiFix Amniotic Membrane Allograft Clinical Trial
SaluDisc
SaluDisc Product Overview
MiMedx Group Inc – Key Competitors
MiMedx Group Inc – Key Employees
MiMedx Group Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
MiMedx Group Inc, Recent Developments
Jul 28, 2020: MiMedx adds Rohit Kashyap, Ph.D., to leadership team as Executive Vice President and Chief Commercial Officer
Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing disclosures
Dec 16, 2019: MiMedx Announces addition of Peter M. Carlson
Nov 26, 2019: SEC charges biotech company and executives with accounting fraud
Nov 26, 2019: MiMedx names William “Butch” Hulse as General Counsel and Secretary
Nov 26, 2019: MiMedx announces Securities and Exchange Commission Settlement
Sep 20, 2019: MiMedx announces resignation of board member
Jun 05, 2019: MiMedx issues new presentation for investors in advance Of 2018 Annual Meeting
May 30, 2019: MiMedx announces comprehensive board refreshment plan in cooperation with prescience point
May 09, 2019: MiMedx appoints Timothy R. Wright as Chief Executive Officer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
MiMedx Group Inc Pipeline Products and Ongoing Clinical Trials Overview
MiMedx Group Inc Pipeline Products by Equipment Type
MiMedx Group Inc Pipeline Products by Indication
MiMedx Group Inc Ongoing Clinical Trials by Trial Status
MiMedx Group Inc, Key Facts
MiMedx Group Inc, Major Products and Services
MiMedx Group Inc Number of Pipeline Products by Development Stage
MiMedx Group Inc Pipeline Products Summary by Development Stage
MiMedx Group Inc Ongoing Clinical Trials by Trial Status
MiMedx Group Inc Ongoing Clinical Trials Summary
AmnioFix Injectable - Achilles Tendonitis - Product Status
AmnioFix Injectable - Achilles Tendonitis - Product Description
AmnioFix Injectable - Achilles Tendonitis - A Phase III Achilles Tendonitis Clinical Study of Investigational New Drug (IND)
AmnioFix Injectable - Knee OA Pain - Product Status
AmnioFix Injectable - Knee OA Pain - Product Description
AmnioFix Injectable - Knee OA Pain - A Phase IIb, Prospective, Double-blinded, Randomized Controlled Study of Regenerative Medicine Advanced Therapy (RMAT) Designated AmnioFix Injectable in the Treatment of Knee Osteoarthritis
AmnioFix Injectable - Plantar Fasciitis - Product Status
AmnioFix Injectable - Plantar Fasciitis - Product Description
AmnioFix Injectable - Plantar Fasciitis - Prospective, Double-blinded, Randomized Controlled Trial of AmnioFix Injectable as Compared to a Saline Placebo Injection in the Treatment of Plantar Fasciitis
AmnioFix Injectable - Pressure Ulcer - Product Status
AmnioFix Injectable - Pressure Ulcer - Product Description
CollaFix - Foot & Ankle - Product Status
CollaFix - Foot & Ankle - Product Description
CollaFix - Rotator Cuff Repair - Product Status
CollaFix - Rotator Cuff Repair - Product Description
CollaFix BioBraid - Product Status
CollaFix BioBraid - Product Description
CollaFix Collagen Fiber Suture - Product Status
CollaFix Collagen Fiber Suture - Product Description
CollaFix Tendon Protector - Product Status
CollaFix Tendon Protector - Product Description
EpiFix Amniotic Membrane Allograft - Product Status
EpiFix Amniotic Membrane Allograft - Product Description
EpiFix Amniotic Membrane Allograft - Clinical Evaluation of EpiFix in venous leg ulcers ("VLUs")
EpiFix Amniotic Membrane Allograft - Limb Salvage Through Tissue Engineering: A Novel Treatment Modality Using Dehydrated Human Amnion/Chorion Membrane
EpiFix Amniotic Membrane Allograft - The Registry of Cellular and Tissue Based Therapies for Chronic Wounds and Ulcers
SaluDisc - Product Status
SaluDisc - Product Description
MiMedx Group Inc, Key Employees
MiMedx Group Inc, Subsidiaries
Glossary

★海外企業調査レポート[MiMedx Group Inc (MDXG):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cheil Worldwide Inc. (030000):企業の財務・戦略的SWOT分析
    Cheil Worldwide Inc. (030000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Re-Vana Therapeutics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Re-Vana Therapeutics Ltd (Re-Vana) is an ocular pharmaceutical and drug delivery company that develops and commercialization of biodegradable long- acting drug delivery platforms to treat ophthalmic conditions. The company provides drug delivery products such as OcuLief, an injectable platfo …
  • McPherson’s Ltd (MCP):企業の財務・戦略的SWOT分析
    McPherson's Ltd (MCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TMX Group Ltd (X)
    TMX Group Ltd (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Edenor SA (EDN3):企業の財務・戦略的SWOT分析
    Edenor SA (EDN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • IndusInd Bank Ltd:企業のM&A・事業提携・投資動向
    IndusInd Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IndusInd Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • EDF Renewable Energy Inc:電力:M&Aディール及び事業提携情報
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. It designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It develops …
  • Natera Inc (NTRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Del Taco Holdings, Inc.:戦略・SWOT・企業財務分析
    Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Astrapak Limited (APK):企業の財務・戦略的SWOT分析
    Astrapak Limited (APK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • LifeScan Inc:企業の戦略的SWOT分析
    LifeScan Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Piksel, Inc.:企業のM&A・事業提携・投資動向
    Piksel, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Piksel, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Regional Express Holdings Limited:企業の戦略・SWOT・財務情報
    Regional Express Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Regional Express Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • SunPower Corporation:企業の戦略・SWOT・財務情報
    SunPower Corporation - Strategy, SWOT and Corporate Finance Report Summary SunPower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Visiomed Group SA (ALVMG):医療機器:M&Aディール及び事業提携情報
    Summary Visiomed Group SA (Visiomed) is a medical device company. The company develops and distributes electronic medical devices. It offers screening and diagnosis products, pain relief products, prevention and treatment products, hearing and optics, family hygiene, children’s optics, baby bottle t …
  • Grid2020, Inc.:電力:M&Aディール及び事業提携情報
    Summary Grid2020, Inc. (Grid2020) is a provider of smart grid solutions. The company offers an integrated distribution transformer monitoring solutions under the brand Optanode. The Optanode product family consists of sensors and smart analytics software and provides information about the distributi …
  • Reliance Industries Limited:企業の戦略・SWOT・財務分析
    Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kumba Iron Ore Ltd:企業の戦略・SWOT・財務情報
    Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report Summary Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Myer Holdings Ltd:企業の戦略・SWOT・財務分析
    Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆